Diet-heart issues in a pharmacological era

Lancet

Volumn 348, Issue SUPPL.1, 1996, Pages

  Kromhout, Daan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; FATTY ACID; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; DIET THERAPY; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL;

EID: 0029846719     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)98007-1     Document Type: Article

References (21)

1. Yusuf S, Anand S. Cost of prevention. The case of lipid lowering. Circulation 1996; 93: 1774-76.
2. Oliver M, Poole-Wilson P, Shepherd J, Tikkanen MJ. Lower patients' cholesterol now. BMJ 1995; 310: 1280-81.
3. The WOSCOPS Study Group. West of Scotland Coronary Prevention Study: implications for clinical practice. Eur Heart J 1996; 17: 163-64.
4. Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in diet: IV, particular saturated fatty acids in the diet. Metabolism 1965; 14: 776-86.
5. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arteriosclerosis Thrombosis 1992; 12: 911-19.
6. Mensink RP, Katan MB. Effect of dietary trans fatty acids on high density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med 1990; 323: 439-45.
7. Kromhout D, Bosschieter EB, De Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312: 1205-09.
8. Wood DA, Riemersma RA, Butler S, et al. Linoleic and eicosapentaenoic acids in adipose tissue and platelets and risk of coronary heart disease. Lancet 1987; i: 177-83.
9. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-24.
10. Greenberg ER, Sporn MB. Antioxidant vitamins, cancer and cardiovascular disease. N Engl J Med 1996; 334: 1189-90.
11. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-86.
12. National Research Council. Diet and health. Implications for reducing chronic disease risk. Washington DC: National Academy Press, 1989.
13. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease. The Zutphen Elderly Study. Lancet 1993; 342: 1007-11.
14. Muldoon MF, Kritchevsky SB. Flavonoids and heart disease. Evidence of benefit still fragmentary. BMJ 1996; 312: 458-59.
15. Serafini M, Ghiselli A, Ferro-Luzzi A. In vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr 1996; 50: 28-32.
16. Kromhout D, Menotti A, Bloemberg B, et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med 1995; 24: 308-15.
17. Hertog MGL, Kromhout D, Aravanis C, et al. Flavonoid intake and longterm risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 1995; 155: 381-86.
18. Truswell AS. Review of dietary intervention studies: effect on coronary events and mortality. Aust NZ J Med 1994; 24: 98-106.
19. de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid rich diet in secondary prevention of coronary heart disease. Lancet 1994; 343: 1454-59.
20. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel II). Circulation 1994; 89: 1329-445.
21. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990; 336: 129-33.